de State Street Sabra Healthcare REIT SBRA Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 240 M | Comprar |
12,305,655
+205,704
| +2% | +USD 4.08 M | 0.01% | 938 |
|
|
2026
Q1 | USD 233 M | Comprar |
12,099,951
+198,311
| +2% | +USD 3.91 M | 0.01% | 869 |
|
|
2025
Q4 | USD 225 M | Vender |
11,901,640
-256,515
| -2% | -USD 4.75 M | 0.01% | 876 |
|
|
2025
Q3 | USD 227 M | Vender |
12,158,155
-139,101
| -1% | -USD 2.6 M | 0.01% | 872 |
|
|
2025
Q2 | USD 227 M | Comprar |
12,297,256
+15,513
| +0.1% | +USD 275 k | 0.01% | 819 |
|
|
2025
Q1 | USD 215 M | Comprar |
12,281,743
+93,891
| +0.8% | +USD 1.58 M | 0.01% | 853 |
|
|
2024
Q4 | USD 211 M | Comprar |
12,187,852
+497,452
| +4% | +USD 9.08 M | 0.01% | 904 |
|
|
2024
Q3 | USD 218 M | Vender |
11,690,400
-123,492
| -1% | -USD 2.08 M | 0.01% | 870 |
|
|
2024
Q2 | USD 182 M | Comprar |
11,813,892
+104,576
| +0.9% | +USD 1.49 M | 0.01% | 911 |
|
|
2024
Q1 | USD 173 M | Vender |
11,709,316
-789,284
| -6% | -USD 10.9 M | 0.01% | 956 |
|
|
2023
Q4 | USD 178 M | Comprar |
12,498,600
+56,525
| +0.5% | +USD 803 k | 0.01% | 917 |
|
|
2023
Q3 | USD 173 M | Comprar |
12,442,075
+128,401
| +1% | +USD 1.64 M | 0.01% | 848 |
|
|
2023
Q2 | USD 145 M | Vender |
12,313,674
-150,668
| -1% | -USD 1.72 M | 0.01% | 985 |
|
|
2023
Q1 | USD 143 M | Vender |
12,464,342
-14,740
| -0.1% | -USD 182 k | 0.01% | 968 |
|
|
2022
Q4 | USD 155 M | Comprar |
12,479,082
+273,193
| +2% | +USD 3.48 M | 0.01% | 888 |
|
|
2022
Q3 | USD 160 M | Comprar |
12,205,889
+81,240
| +0.7% | +USD 1.2 M | 0.01% | 825 |
|
|
2022
Q2 | USD 169 M | Comprar |
12,124,649
+88,883
| +0.7% | +USD 1.19 M | 0.01% | 825 |
|
|
2022
Q1 | USD 179 M | Comprar |
12,035,766
+1,840,939
| +18% | +USD 25.2 M | 0.01% | 906 |
|
|
2021
Q4 | USD 138 M | Comprar |
10,194,827
+1,006,444
| +11% | +USD 14.2 M | 0.01% | 1056 |
|
|
2021
Q3 | USD 135 M | Comprar |
9,188,383
+499,491
| +6% | +USD 8.44 M | 0.01% | 1050 |
|
|
2021
Q2 | USD 158 M | Comprar |
8,688,892
+285,797
| +3% | +USD 5.09 M | 0.01% | 985 |
|
|
2021
Q1 | USD 146 M | Vender |
8,403,095
-144,728
| -2% | -USD 2.55 M | 0.01% | 963 |
|
|
2020
Q4 | USD 148 M | Comprar |
8,547,823
+7,822
| +0.1% | +USD 125 k | 0.01% | 889 |
|
|
2020
Q3 | USD 118 M | Vender |
8,540,001
-710,076
| -8% | -USD 10.4 M | 0.01% | 884 |
|
|
2020
Q2 | USD 133 M | Vender |
9,250,077
-154,420
| -2% | -USD 2.03 M | 0.01% | 810 |
|
|
2020
Q1 | USD 103 M | Comprar |
9,404,497
+1,477,687
| +19% | +USD 27.2 M | 0.01% | 840 |
|
|
2019
Q4 | USD 169 M | Vender |
7,926,810
-545,183
| -6% | -USD 12.2 M | 0.01% | 765 |
|
|
2019
Q3 | USD 195 M | Comprar |
8,471,993
+320,001
| +4% | +USD 6.83 M | 0.01% | 693 |
|
|
2019
Q2 | USD 161 M | Comprar |
8,151,992
+704,543
| +9% | +USD 13.7 M | 0.01% | 767 |
|
|
2019
Q1 | USD 145 M | Comprar |
7,447,449
+1,253,289
| +20% | +USD 23.7 M | 0.01% | 800 |
|
|
2018
Q4 | USD 102 M | Vender |
6,194,160
-369,336
| -6% | -USD 7.44 M | 0.01% | 896 |
|
|
2018
Q3 | USD 152 M | Comprar |
6,563,496
+131,375
| +2% | +USD 2.98 M | 0.01% | 829 |
|
|
2018
Q2 | USD 140 M | Vender |
6,432,121
-173,284
| -3% | -USD 3.38 M | 0.01% | 839 |
|
|
2018
Q1 | USD 117 M | Vender |
6,605,405
-45,130
| -0.7% | -USD 795 k | 0.01% | 925 |
|
|
2017
Q4 | USD 125 M | Comprar |
6,650,535
+654,153
| +11% | +USD 13 M | 0.01% | 906 |
|
|
2017
Q3 | USD 132 M | Comprar |
5,996,382
+4,220,394
| +238% | +USD 95.3 M | 0.01% | 836 |
|
|
2017
Q2 | USD 42.8 M | Comprar |
1,775,988
+65,393
| +4% | +USD 1.66 M | ﹤0.01% | 1456 |
|
|
2017
Q1 | USD 47.8 M | Comprar |
1,710,595
+137,778
| +9% | +USD 3.61 M | ﹤0.01% | 1354 |
|
|
2016
Q4 | USD 38.4 M | Comprar |
1,572,817
+167,688
| +12% | +USD 3.84 M | ﹤0.01% | 1428 |
|
|
2016
Q3 | USD 35.4 M | Comprar |
1,405,129
+57,626
| +4% | +USD 1.38 M | ﹤0.01% | 1409 |
|
|
2016
Q2 | USD 27.8 M | Comprar |
1,347,503
+32,672
| +2% | +USD 681 k | ﹤0.01% | 1523 |
|
|
2016
Q1 | USD 26.4 M | Comprar |
1,314,831
+48,078
| +4% | +USD 922 k | ﹤0.01% | 1526 |
|
|
2015
Q4 | USD 25.6 M | Comprar |
1,266,753
+5,268
| +0.4% | +USD 111 k | ﹤0.01% | 1536 |
|
|
2015
Q3 | USD 29.2 M | Comprar |
1,261,485
+32,747
| +3% | +USD 836 k | ﹤0.01% | 1497 |
|
|
2015
Q2 | USD 31.6 M | Comprar |
1,228,738
+68,512
| +6% | +USD 1.95 M | ﹤0.01% | 1559 |
|
|
2015
Q1 | USD 38.5 M | Comprar |
1,160,226
+168,528
| +17% | +USD 5.47 M | ﹤0.01% | 1389 |
|
|
2014
Q4 | USD 30.1 M | Comprar |
991,698
+86,641
| +10% | +USD 2.39 M | ﹤0.01% | 1506 |
|
|
2014
Q3 | USD 22 M | Vender |
905,057
-25,780
| -3% | -USD 715 k | ﹤0.01% | 1670 |
|
|
2014
Q2 | USD 26.7 M | Comprar |
930,837
+150,371
| +19% | +USD 4.37 M | ﹤0.01% | 1616 |
|
|
2014
Q1 | USD 21.8 M | Comprar |
780,466
+19,650
| +3% | +USD 540 k | ﹤0.01% | 1720 |
|
|
2013
Q4 | USD 19.9 M | Comprar |
760,816
+6,201
| +0.8% | +USD 160 k | ﹤0.01% | 1757 |
|
|
2013
Q3 | USD 17.4 M | Vender |
754,615
-2,221
| -0.3% | -USD 54.7 k | ﹤0.01% | 1792 |
|
|
2013
Q2 | USD 19.8 M | Comprar |
+756,836
| Nuevas | +USD 21.8 M | ﹤0.01% | 1638 |
|
Otros fondos que tienen SBRA en su cartera
Posición de State Street en SBRA: resumen de T2 2026
State Street aumentó su participación en Sabra Healthcare REIT (SBRA) en 1.7% durante T2 2026, al comprar aproximadamente USD 4.08 M y elevar la posición a 12,305,655 acciones con un valor de USD 240 M. La posición representa 0.01% de la cartera y ocupa el puesto #938.
State Street reportó por primera vez una posición en SBRA en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 467 fondos que sigue Wall St. Rank mantienen una posición en SBRA.
- Al cierre de T2 2026, State Street tenía 12,305,655 acciones de Sabra Healthcare REIT con un valor de USD 240 M.
- State Street compró 205,704 acciones de Sabra Healthcare REIT en T2 2026, por un monto estimado de USD 4.08 M.
- Sabra Healthcare REIT representó 0.01% de la cartera de State Street en T2 2026 y fue su posición número 938.
- State Street reportó por primera vez una posición en Sabra Healthcare REIT en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 467 fondos que sigue Wall St. Rank tenían Sabra Healthcare REIT en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.